U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Commission File Number 000-28443
(Check one): [X] Form 10-K and Form 10-KSB [ ] Form 11-K
[ ] Form 20-F [ ] Form 10-Q and Form 10-QSB
[ ] Form N-SAR
For period ended December 31, 1999
Transition Report on Form 10-K and 10-KSB
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q and Form 10-QSB
Transition Report on Form N-SAR
For the transition period ended
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
Full name of registrant: Autologous Wound Therapy, Inc.
Former name if applicable:
Address of principal executive office: 1523 Bowman Road, Suite A
(Street and Number)
City, State and Zip Code: Little Rock, Arkansas 72211
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should be
completed. (Check appropriate box.)
[ ] (a) The reasons described in reasonable
detail in Part III of this form could not be
eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual
report, transition report on Forms 10-K,
10-KSB, 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th
calendar day following the prescribed due
date; or the subject quarterly report or
transition report on Form 10-Q, 10-QSB, or
portion thereof will be filed on or before
the fifth calendar day following the
prescribed due date; and
[X] (c) The accountant's statement or other
exhibit required by Rule 12b-25(c) has been
attached if applicable.
PART III
NARRATIVE
The Registrant's independent auditor's have not
yet completed the audit of the Registrant's
December 31, 1999 consolidated financial
statements.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in
regard to this notification.
Dennis G. Hendren (501) 225-8400
(name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under
Section 13 or 15(d) or the Securities Exchange Act
of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months
or for such shorter period that the registrant was
required to file such report(s) been filed? If
the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in
results of operations from the corresponding
2
period for the last fiscal year will be reflected
by the earnings statements to be included in the
subject report or portion thereof?
[X] Yes [ ] No
The Registrant is awaiting on certain information
to complete the company s fiscal year end audit
and as a development stage entity, the results of
the Registrant will significantly change from the
prior fiscal year ending December 31, 1998.
Autologous Wound Therapy, Inc.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: March 30, 2000 By: /s/ Dennis G. Hendren
------------------------------
Dennis G. Hendren, President
3
L J Soldinger Associates
3850 North Wilke Road
Arlington Heights, IL 60004
March 29, 2000
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, D.C. 20549
Gentlemen:
This letter is written in response to the requirements
of Rule 12b-25 under the Securities Exchange Act of 1934 and
in satisfaction of Item (c) of Part II of Form 12b-25.
We are the independent auditors of Autologous Wound
Therapy, Inc. (the "Registrant"). The Registrant has stated
in Part III of its filing on Form 12b-25 that it is unable
to timely file its Annual Report on Form 10-KSB for the year
ended December 31, 1999, without unreasonable effort or
expense because, among other reasons, we have be unable
to complete our audit of the financial statements of the
Registrant for the year ended December 31, 1999, and are,
therefore, unable to furnish the required opinion on such
financial statements.
We hereby advise you that we have read the statement
made by the Registrant in Part III of its filing on Form
12b-25 and agree with the statements made therein.
VERY TRULY YOURS,
/s/ L J Soldinger Associates
L J Soldinger Associates